The gene therapy sector plays a significant role in supporting modern precision-medicine approaches by providing viral and non-viral vector-based treatments for monogenic disorders, hematological conditions, and select oncology indications. Developers are increasingly incorporating next-generation vector engineering and improved manufacturing platforms that improve treatment efficacy and safety...